SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Ann‐Sofie Rudberg, Sebastian Havervall, Anna Månberg, +21

Nature Communications

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

Katarina Tengvall, Jesse Huang, Cecilia Hellström, +22

Proceedings of the National Academy of Sciences

Integration of molecular profiles in a longitudinal wellness profiling cohort

Abdellah Tebani, Anders Gummesson, Wen Zhong, +35

Nature Communications

Genetic EpidemiologyMultiomicsLongitudinal WellnessLongitudinal Wellness CohortProspective Cohort Study +16

Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer

Dijana Djureinovic, Tea Dodig‐Crnković, Cecilia Hellström, +7

Lung Cancer

Autoimmune DiseaseAutoantibody ProductionCancer DetectionMedicineImmunology +12

Individual and stable autoantibody repertoires in healthy individuals

Maja Neiman, Cecilia Hellström, David Just, +10

Autoimmunity

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19

Sebastian Havervall, Henry Ng, August Jernbom Falk, +27

Journal of Internal Medicine

Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling

Ronald Sjöberg, Cecilia Mattsson, Eni Andersson, +5

New Biotechnology

High-density Protein MicroarraysAutoimmune DiseaseAntibody ValidationImmunologyComputational Biology +12

Array-Based Profiling of Proteins and Autoantibody Repertoires in CSF

Elisa Pin, Ronald Sjöberg, Eni Andersson, +8

Methods in molecular biology

Sequence MotifFunctional GenomicsEngineeringMedicineGenetics +9

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys

Hassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, +12

The Journal of Infectious Diseases

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2

Sebastian Havervall, Ulrika Marking, Nina Greilert‐Norin, +13

EBioMedicine